Adherence and persistence to rivaroxaban in non-valvular atrial fibrillation patients receiving 30- or 90-day supply prescription fills

CONCLUSIONS: Dispensing 90-day supply fills of rivaroxaban appears to increase the proportion of patients achieving acceptable (PDC ≥80%) adherence as well as mean adherence compared to 30-day supply fills. Ninety-day rivaroxaban fills may also result in improved persistence versus 30-day fills.PMID:34581258 | DOI:10.1080/03007995.2021.1985987
Source: Current Medical Research and Opinion - Category: Research Authors: Source Type: research